Stage IVA Nasopharyngeal Carcinoma AJCC v8

5 clinical trials · Condition

Record	Firm	Date
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer (NCT06980038)	National Cancer Institute (NCI)	2026-05-27
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer (NCT06532279)	NRG Oncology	2025-06-23
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma (NCT06682442)	University of California, San Francisco	2025-03-18
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer (NCT04458909)	National Cancer Institute (NCI)	2020-12-09
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150)	M.D. Anderson Cancer Center	2016-12-29

Every clearance here is in the API, with alerts when new ones post.